Trial · NCT01500109
Efficacy of Oral Versus Intravenous Acetaminophen for Primary Pediatric Cleft Palate Repair
NCT01500109, Not applicable, Completed, Loma Linda University; results first posted 2015-04-01
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Efficacy of Oral Versus Intravenous Acetaminophen for Primary Pediatric Cleft Palate Repair. Trials, record NCT01500109. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01500109
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Efficacy of Oral Versus Intravenous Acetaminophen for Primary Pediatric Cleft Palate Repair
- NCT number
- NCT01500109
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 45 participants, actual
- Lead sponsor
- Loma Linda University
- Conditions
- Cleft Palate
- Interventions
- Oral acetaminophen, Ofirmev®, Opioid only
- First posted
- 2011-12-26
- Last updated
- 2021-06-09
- Results first posted
- 2015-04-01
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Opioid (Fentanyl and Morphine) Consumption | intraoperative period and first postoperative 24 hours | The primary outcome measure of the study will be to measure opioid (Fentanyl and Morphine) consumption during the intraoperative period first postoperative 24 hours (measured in morphine equivalents). |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Opioid (Fentanyl and Morphine) Consumption | intraoperative period and first postoperative 24 hours | PI left institution without completing results. All efforts to contact PI for data have been unsuccessful. No data available to report. |
Source ClinicalTrials.gov
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow9
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Ofirmev® | 0 | |
| Overall Study | STARTED | Oral Acetaminophen | 0 | |
| Overall Study | STARTED | Opioid Only | 0 | |
| Overall Study | COMPLETED | Ofirmev® | 0 | |
| Overall Study | COMPLETED | Oral Acetaminophen | 0 | |
| Overall Study | COMPLETED | Opioid Only | 0 | |
| Overall Study | NOT COMPLETED | Ofirmev® | 0 | |
| Overall Study | NOT COMPLETED | Oral Acetaminophen | 0 | |
| Overall Study | NOT COMPLETED | Opioid Only | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals9
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Ofirmev® | ||
| Total, all-cause mortality | Oral Acetaminophen | ||
| Total, all-cause mortality | Opioid Only | ||
| Total, other adverse events | Ofirmev® | 0 | 0 |
| Total, other adverse events | Oral Acetaminophen | 0 | 0 |
| Total, other adverse events | Opioid Only | 0 | 0 |
| Total, serious adverse events | Ofirmev® | 0 | 0 |
| Total, serious adverse events | Oral Acetaminophen | 0 | 0 |
| Total, serious adverse events | Opioid Only | 0 | 0 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01500109
GET https://conductscience.org/api/trials/v1/NCT01500109/registered